# Shanghai Longhui Medical Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shanghai-longhui-medical-technology-co

- Industry: Medical Devices & Equipment
- Headquarters: China
- Website: www.longwellrobot.com
- Total disclosed funding: $15M
- Latest round: Series B (Nov 25, 2021)
- Investors on record: 3

## About

Based in Shanghai, China, Shanghai Longhui Medical Technology Co., Ltd., doing business as Longwell Robot, operates as a health technology firm that develops joint replacement surgery robots to aid surgeons during the procedure. The company raised USD 15 million in round B funding in November 2021, led by new investors Sunland Capital and Sinopharm Capital and with participation from another new investor, FTZ Fund.

Shanghai Longhui Medical Technology Co., Ltd. is engaged in the development and distribution of joint replacement surgery robots. The firm’s product suite comprises TRex-RS, the robot that performs total hip replacement surgery with high precision and minimal time, and its features include “six degrees of freedom” and real-time tracking capabilities, which eliminates errors caused by patient displacement during surgery. The company also provides value-added services including product integration, maintenance, and repair.

## Funding rounds

- Series B, Nov 25, 2021, $15M — Shanghai Jianyi Private Equity Fund Management, Sunland Capital, FTZ Fund

## Investors

- Shanghai Jianyi Private Equity Fund Management (https://capitalatlas.ai/funds/shanghai-jianyi-private-equity-fund-management) — Series B
- Sunland Capital — Series B
- FTZ Fund (https://capitalatlas.ai/funds/ftz-fund) — Series B